Nutrition 21 litigation
This article was originally published in The Tan Sheet
Executive Summary
Purchase N.Y.-based firm files motion for partial summary judgement against InterHealth Nutraceuticals to halt six alleged instances of false advertising for ChromeMate chromium nicotinate dietary supplement. In complaint, filed in Manhattan federal court Sept. 24, Nutrition 21 asserts InterHealth ads have misled consumers about the safety of ChromeMate respective to Nutrition 21's Chromax chromium picolinate dietary supplement. Company is seeking damages including judgement that ads are false, corrective advertising and monetary damages, according to a spokesperson...
You may also be interested in...
EU MDR Notified Body Designations Could Soar By A Third By End 2021
There could be 28 notified body designations in total under the Medical Device Regulation by the end of 2021. But there is cause for concern over designations under the IVD Regulation, which are lagging far behind.
Swiss Health Providers Turn Heat On Federal Council: 12% Loss Of Medtech Products Likely On EU MRA Failure
A consortium of Swiss providers, patient groups and health care trade bodies is imploring the federal council to avert a looming patient care crisis in Switzerland if the EU MRA cannot be agreed.
New China COVID Vaccine Arriving But COVAX Pledge May Need A Booster
China’s first domestically-developed recombinant protein vaccine for COVID-19 moves forward in late-stage trials in two countries.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: